MBRX, PWRM, CBS, CSRH, CVC, CVAT, NOC, AQNM, UTX, DrStockPick.com Stock Report!
Dr Stock Pick HOT News & Alerts!
_________________________________________
FREE Daily Stock Alerts From DrStockPick.com
_________________________________________
Friday October 9, 2009
DrStockPick.com Stock Report!
MBRX, PWRM, CBS, CSRH, CVC, CVAT, NOC, AQNM, UTX
**************************************************************
MBRX, Metabasis Therapeutics Inc.
MBRX, a biopharmaceutical company, engages in the discovery, development, and commercialization of novel drugs targeting the liver and liver pathways.
On September 15, 2009, MBRX received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”), notifying the Company that based upon the closing bid price of its common stock for the last 30 consecutive business days, the Company did not maintain a minimum closing bid price of $1.00 per share or more that is required for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). Under Nasdaq Listing Rule 5810(c)(3)(A), the Company has a grace period of 180 calendar days, or until March 15, 2010, in which to regain compliance. If at anytime during this grace period the closing bid price of the Company’s common stock is $1.00 per share or more for a minimum of 10 consecutive business days, Nasdaq will provide the Company with written confirmation of regained compliance.
**************************************************************
PWRM, Power 3 Medical Products Inc, PWRM.OB
Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug targets. Power3’s patent-pending technologies are being used to develop screening and diagnostic tests for the early detection and prognosis of disease, identify protein biomarkers, and drug targets. Diagnostic tests are targeted toward markets with critical unmet needs in areas including neurodegenerative disease (NuroPro) and breast cancer (BC-SeraPro). Power3 expects to complete phase II clinical validation trials of its blood serum diagnostics for Alzheimer’s disease (NuroPro-AD), and Parkinson’s disease (NuroPro-PD) in 2009 and for breast cancer in 2010, followed by filings with the FDA. Power3 operates a state-of-the-art CLIA certified laboratory in The Woodlands (Houston), Texas. Power3 continues to evolve and enhance its IP portfolio, employing sensitive and specific combinations of biomarkers it has discovered from a broad range of diseases as the basis of highly selective blood-based tests for ALS, Alzheimer’s, and Parkinson’s diseases, and breast cancer.
PWRM Announced that its Chief Scientific Officer is Chair and Keynote Speaker of Session at the BTI Life Sciences 2nd Annual Congress and Expo of Molecular Diagnostics in Beijing, China in November 2009
Further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of Personalized Medicine.”
More about PWRM at www.power3medical.com
**************************************************************
CBS, CBS Corporation and CVC, Cablevision Systems Corporation
CBS is a mass media company with constituent parts that reach back to the beginnings of the broadcast industry, as well as newer businesses that operate on the leading edge of the media industry.
CVC is one of the nation’s leading media and entertainment companies. Its cable television operations serve more than 3 million households in the New York metropolitan area.
CVC and CBS today announced a comprehensive content carriage agreement under which Cablevision will continue to carry CBS programming and offer Showtime Networks’ programming to Cablevision’s three million subscribers in New York, New Jersey and Connecticut. In the New York metropolitan market, Cablevision will continue to carry WCBS2. Its customers in central and southern New Jersey will receive Philadelphia’s KYW (CBS) and WPSG (CW).
**************************************************************
CSRH, Consorteum Holdings Inc, CSRH.OB
CSRH announced a corporate update with respect to its business activities. Over the course of the past 60 days, several meetings and presentations have occurred between the Company’s management and various corporations, private and public, to further the development of the company’s Card Programs, Merchant Discount Rates and new Joint Venture business relationship. As a result of these meetings, we have identified several new key business opportunities that will lead to increased revenues in 2010-2011.
As previously announced, we have signed a joint venture agreement with Trans Screen Group. Through this newly established joint venture relationship, Trans Screen Group and Consorteum Holdings Inc. will expand into markets outside North America targeting new opportunities in India, Africa, Russia, Latin America, Thailand and China for payroll / benefits cards, loyalty programs, gift cards, payment transaction processing and several other value added services. The Trans Screen Group has established business relationships within these countries and will leverage Consorteum’s expertise to provide financial services to their existing partners.
Consorteum has also been in discussion with several companies within the payroll industry to develop new payroll card programs. Proposals have been presented and we will continue to develop these relationships to reach the deployment phase.
Furthermore, “My Golf Rewards” finalized its pilot program over the summer and has completed all testing and platform development. The next phase of engagement is adding 20 new golf courses to the program in early 2010. We are also planning to further expose the My Golf Rewards program to golf courses owners and end consumers through trade shows and industry publications.
We continue to explore adding industry professionals and experts who have experience in the areas of banking, credit card issuance, payment processing, rebates and payroll. In addition, the Company is currently looking to expand its Board of Directors and Board of Advisors with financial services industry experts and senior executive level professionals running successful and profitable organizations. We will be providing further press releases and corporate updates to our shareholders and the investment community within the next 30 days.
More about CSRH at www.consorteum.com
**************************************************************
NOC, Northrop Grumman Corporation
NOC provides products, services, and solutions in information and services, aerospace, electronics, and shipbuilding in the United States.
A unit of NOC received a $5.7 million contract from U.S. Special Operations Command for an operational-management system
**************************************************************
CVAT, Cavitation Technologies Inc, CVAT.OB
CVAT has announced that it has filed PCT patent applications for new International Patent protections for its Nano Cavitation Technologies.
According to Igor Gorodnitsky, CTI’s President and Director of Research and Development, “CTI continues to identify new applications for our technology. All of the applications are in industries where there is a need to solve environmental problems, reduce operating costs and improve profitability. We have hundreds of international inquiries from companies that want our technology and as a result we needed to file International Patents to protect our Intellectual Property worldwide. These technologies have significant benefit and value for the vegetable oil refining, renewable fuels, petroleum, water desalination, wastewater treatment, food and beverage, chemical industries.”
As indicated by the patent attorney from the firm Kelly Lowry and Kelley, “Some of the CTI applications have been filed so as to protect the various highly innovative technologies developed by Cavitation Technologies, Inc. concerning industries needing Green technologies to reduce their carbon footprint, reduce the use of chemicals and costs.”
These PCT international CTI applications should be published by the end of August 2010. The Company looks forward to proceeding with the national phase entries in various countries in order to protect its technologies in countries.
“We are particularly proud of the fact that the technologies we are developing will have international impact,” indicated Roman Gordon, Cavitation Technologies, Inc. CEO. “As we continue to develop our intellectual property portfolio, we are also exploring relationships with potential strategic partners to enable worldwide transformation of a number of chemical, wastewater, renewable fuels and vegetable oil processes.”
CVAT More about CVAT at www.cavitationtechnologies.com
**************************************************************
UTX, United Technologies Corp.
UTX provides technology products and services to the building systems and aerospace industries worldwide.
Sikorsky Aircraft Corp.’s X2 Technology(TM) demonstrator program has been recognized by Popular Mechanics magazine with a 2009 Breakthrough Innovator Award. Sikorsky is a subsidiary of UTX
**************************************************************
AQNM, Aquentium, Inc., AQNM.OB
Aquentium, Inc. (OTCBB: AQNM) a publicly traded company with a focus on “green technologies” is pleased to announce that the company’s non-chemical technology sanitizes fruits and vegetables naturally without the use of any chemicals.
The Aquentium non-chemical sanitation equipment is designed for improved food safety standards both domestically and internationally. Aquentium is currently offering exclusive representation opportunities for its complete line of non-chemical processing and sanitation equipment for fruits and vegetables in countries throughout the world as well in all fifty states in the USA
The goal at Aquentium is to help prevent contamination of fresh fruits and vegetables. The Aquentium non-chemical process can extend the shelf life of produce which means higher profits for food processors and less waste for the consumer.
The uniqueness of the Aquentium technology is that it is over 50% more effective than chemicals and over 3,000 times faster acting than chemicals. Ultimately, Aquentium believes that we have better technology to combat e-coli, salmonella, listeria and other bacteria or viruses than what most food processors are currently using.
With the Aquentium equipment, a processor does not have to stop processing to do plant sanitation. This increases plant production. Furthermore, food processors can expect an ROI in less than 12 months using the Aquentium equipment.
More about AQNM at www.aquentium.com
**************************************************************
Keep a close eye on MBRX, PWRM, CBS, CSRH, CVC, CVAT, NOC, AQNM and UTX do your homework, and like always BE READY for the ACTION!
***********Advertisement***********
********************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com End Of day publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.
Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick Stock Watch report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur.
Disclaimer: Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. (read more) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has previously received five hundred thousand shares compensation for 30 days of advertisement services and expects to receive an additional 1,000,000 shares 144 restricted stocks for 6 months of advertisement and diseminate news for Power 3 Medical Products Inc. (PWRM.OB). Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand shares of free trading stock from a third party for advertising services for Cavitation Technologies, Inc. (CVAT.OB) and an additional twenty-five thousand shares of 144 restricted stock from Cavitation Technologies, Inc. (CVAT.OB) for 12 months of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received five thousand dollars from Consorteum Holdings Inc. for 30 days of advertisement services. Crown Equity Holdings, Inc. (CRWE.OB) has received 78,000 free trading and 500,000 144 (restricted) shares from a third party for 6 months of advertising services Consorteum Holdings Inc, (CSRH.OB).
_______________________________________________________
_______________________________________________________
Dr. Stock Pick
is a seasoned equity trader and financial investor. He’s on the Crown Equity Holdings, Inc (CRWE.OB) financial staff as a professional investment analyst and consultant. He’s syndicated on over 1000 websites www.crwenews.com, www.stock-ir.com giving daily, up to the minute information about stocks, options, currencies and more. www.drstockpick.com
email: investor@drstockpick.com
Dr Stock Pick would like to invite you to www.crowntradingsystems.com so you can check out the super 16 multi monitor super computer he trades on daily. If you’re looking for a multi display computer to enhance your trading then you’ll want to visit www.crowntradingsystems.com
